 "No painkillers or paracetamol recommended after Covaxin jab: Bharat Biotech")
No paracetamol or painkiller is recommended after being vaccinated with COVID-19 vaccine Covaxin, Bharat Biotech said on Wednesday.
"We have received feedback that certain immunisation centres are recommending taking three paracetamol 500 mg tablets along with Covaxin for children. No paracetamol or painkillers are recommended after being vaccinated with Covaxin, Bharat Biotech said in a Twitter post.
Through the clinical trials spanning about 30,000 individuals, approximately 10 to 20 per cent have reported side effects and most of them were mild, resolved within one or two days, and did not require any medication, the company further said.
Medication is recommended only after consultation with a physician, the vaccine maker said.
Paracetamol was recommended along with other COVID-19 vaccines only and is not prescribed for Covaxin, it added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app